Clovis Oncology (CLVS) Misses Q4 EPS Views

Go back to Clovis Oncology (CLVS) Misses Q4 EPS Views

Form 8-K Clovis Oncology, Inc. For: Feb 25

February 25, 2016 4:13 PM EST


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 25, 2016


Clovis Oncology, Inc.
(Exact name of registrant as specified in its charter)


... More